medi5752: novel pd-1/ctla-4 bispecific checkpoint inhibitor for advanced solid tumors
Published 2 years ago • 293 plays • Length 1:56Download video MP4
Download video MP3
Similar videos
-
3:36
medi5752: first-in-human trial of a novel pd-1 and ctla-4 bispecific checkpoint inhibitor
-
0:18
future research directions for the novel pd-1 and ctla-4 bispecific checkpoint inhibitor, medi5752
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
5:33
cancer immune checkpoint inhibitors
-
2:35
beyond anti-pd-1 and anti-ctla-4 in melanoma
-
1:50
immune checkpoint inhibitors
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
5:10
introduction to immune checkpoint inhibitor (ici) immunotherapy
-
10:27
immunotherapy for cancer treatment: new hope or more hype?
-
21:38
toutes vos questions sur le foie
-
0:24
how can we incorporate checkpoint inhibition in microsatellite stable colorectal cancer?
-
6:31
what are checkpoint inhibitors?
-
1:15
overcoming immune checkpoint inhibitor resistance in kidney cancer
-
1:16
explaining immunotherapy, pd-l1 and pd-1
-
52:27
immunotherapy/checkpoint inhibitor, targeted immunotherapy drugs 5/2/18
-
0:58
what are immune checkpoints?
-
1:44
immune checkpoint inhibitors in mcrpc
-
0:48
immune checkpoint inhibitors in ovarian cancer
-
3:30
side effects of immune checkpoint inhibitors
-
1:02
how useful are checkpoint inhibitors in the treatment of breast cancer?
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
4:13
immunotherapy using checkpoint inhibitors (subtitles)